SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012647
Filing Date
2016-04-28
Accepted
2016-04-28 07:01:30
Documents
7
Period of Report
2016-06-10
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228373zdef14a.htm DEF 14A 775182
2 G929213.JPG g929213.jpg GRAPHIC 8644
3 G683229.JPG g683229.jpg GRAPHIC 6822
4 G198666.JPG g198666.jpg GRAPHIC 2956
5 G67088.JPG g67088.jpg GRAPHIC 22698
6 G24872BGI001.GIF g24872bgi001.gif GRAPHIC 76047
7 G24872BGI002.GIF g24872bgi002.gif GRAPHIC 65905
  Complete submission text file 0001047469-16-012647.txt   1029107
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 161597070
SIC: 2834 Pharmaceutical Preparations